The Dean of the University of Maryland School of Medicine, Prof Mark T. Gladwin, has praised the Institute of Human Virology Nigeria (IHVN) for its achievements in HIV prevention, treatment, and care in Nigeria.
In a message to the University of Maryland School of Medicine community, the Dean stated that he was particularly impressed with IHVN which is led by shared faculty members: Patrick Dakum, Chief Executive Officer, and Associate Professor in the Department of Epidemiology & Public Health; Charles Mensah, Chief Operating Officer; and Alash’le Abimiku, Professor in the Department of Medicine and Executive Director of the International Research Center of Excellence (IRCE).
“IHVN has partnered with the University of Maryland’s Institute of Human Virology to screen more than 8 million people in Africa. We currently have 300,000 patients on active therapy in Nigeria alone. We visited sickle cell and oncology programs and discussed how we can leverage our 25 years of partnership with Nigeria to extend our collaborations in hopes of addressing the ‘epidemics’ of non-communicable diseases, including cancer, cardiovascular disease, and sickle cell anemia,” he said.
Prof Gladwin visited Nigeria and participated in the International Research Center of Excellence (IRCE) 2nd Annual Scientific Symposium. He also visited government officials, the Hon Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, leaders of the Nigeria Sovereign Investment Authority, Lagos University Teaching Hospital, and the University of Abuja.
For more information on the Dean’s message, visit Dean's Message | September 4, 2024 (constantcontact.com)
